Literature DB >> 4356602

Transport of methotrexate into normal haemopoietic cells and into leukaemic cells and its effects on DNA synthesis.

V Hoffbrand, E Tripp, D Catovsky, K C Das.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1973        PMID: 4356602     DOI: 10.1111/j.1365-2141.1973.tb01762.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN: 0007-1048            Impact factor:   6.998


× No keyword cloud information.
  6 in total

1.  Different methotrexate effects in cultured normal and leukaemic human leukocytes.

Authors:  D Rozynkowa; J Stepień; Z Rupniewska
Journal:  Experientia       Date:  1982-06-15

2.  Megaloblastic hematopoiesis in vitro. Interaction of anti-folate receptor antibodies with hematopoietic progenitor cells leads to a proliferative response independent of megaloblastic changes.

Authors:  A C Antony; R A Briddell; J E Brandt; J E Straneva; R S Verma; M E Miller; L A Kalasinski; R Hoffman
Journal:  J Clin Invest       Date:  1991-01       Impact factor: 14.808

3.  Folate (pteroylglutamate) uptake in human red blood cells, erythroid precursors and KB cells at high extracellular folate concentrations. Evidence against a role for specific folate-binding and transport proteins.

Authors:  A C Antony; M A Kane; S R Krishnan; R S Kincade; R S Verma
Journal:  Biochem J       Date:  1989-06-01       Impact factor: 3.857

4.  Identification of high affinity folate binding proteins in human erythrocyte membranes.

Authors:  A C Antony; R S Kincade; R S Verma; S R Krishnan
Journal:  J Clin Invest       Date:  1987-09       Impact factor: 14.808

5.  The role of folates in the development of methotrexate resistance in human leukemia cell line K562.

Authors:  H Miyachi; Y Takemura; Y Ando; K J Scanlon
Journal:  J Cancer Res Clin Oncol       Date:  1992       Impact factor: 4.553

6.  In vitro correlates of clinical response to methotrexate in actue leukaemia and Burkitt's lymphoma.

Authors:  R A Bender; W A Bleyer; J C Drake; J L Ziegler
Journal:  Br J Cancer       Date:  1976-11       Impact factor: 7.640

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.